Table 2.
Characteristics | n † | Prevalence ‡ (%) | Awareness § (%) | Treatment ¶ (%) | Control †† (%) |
---|---|---|---|---|---|
Sex | |||||
Male | 54,794 (40.48) | 10,645 (19.43) | 5,832 (54.79) | 4,911 (46.13) | 1,903 (17.88) |
Female | 80,558 (59.52) | 14,156 (17.58) | 8,089 (57.14) | 6,983 (49.33) | 2,634 (18.61) |
χ2 | 75.34* | 13.69* | 24.84* | 2.93 | |
Age (years) | |||||
≥35 | 5,903 (4.36) | 255 (4.32) | 67 (26.27) | 45 (17.65) | 19 (7.45) |
≥40 | 29,533 (21.82) | 2,560 (8.67) | 960 (37.50) | 755 (29.49) | 309 (12.07) |
≥50 | 42,288 (31.24) | 7,392 (17.48) | 3,972 (53.73) | 3,302 (44.67) | 1,260 (17.05) |
≥60 | 43,509 (32.15) | 10,691 (24.57) | 6,501 (60.81) | 5,628 (52.64) | 2,159 (20.19) |
≥70~75 | 14,119 (10.43) | 3,903 (27.64) | 2,421 (62.03) | 2,164 (55.44) | 790 (20.24) |
trendχ2 | 4,590.49* | 620.55* | 657.29* | 131.21* | |
Urban and rural | |||||
Urban | 39,629 (29.28) | 8,444 (21.31) | 5,504 (65.18) | 4,735 (56.08) | 2,098 (24.85) |
Rural | 95,723 (70.72) | 16,357 (17.09) | 8,417 (51.46) | 7,159 (43.77) | 2,439 (14.91) |
χ2 | 334.38* | 425.99* | 338.03* | 368.2* | |
High school or above | |||||
Yes | 31,157 (23.02) | 5,064 (16.25) | 3,045 (60.13) | 2,510 (49.57) | 1,163 (22.97) |
No | 104,195 (76.98) | 19,737 (18.94) | 10,876 (55.10) | 9,384 (47.55) | 3,374 (17.09) |
χ2 | 117.47* | 41.34* | 23.14* | 93.17* | |
Annual family income ≥50,000 RMB | |||||
Yes | 40,829 (30.17) | 6,886 (16.87) | 4,120 (59.83) | 3,531 (51.28) | 1,422 (20.65) |
No | 94,523 (69.83) | 17,915 (18.95) | 9,801 (54.71) | 8,363 (46.68) | 3,115 (17.39) |
χ2 | 83.74* | 53.02* | 42.11* | 35.79* | |
Married | |||||
Yes | 124,078 (91.67) | 22,461 (18.10) | 12,545 (55.85) | 10,690 (47.59) | 4,093 (18.22) |
No | 11,274 (8.33) | 2,340 (20.76) | 1,376 (58.80) | 1,204 (51.45) | 444 (18.98) |
χ2 | 50.12* | 7.5* | 12.65* | 0.90 | |
Medical insurance | |||||
Yes | 131,440 (97.11) | 23,915 (18.19) | 13,399 (56.03) | 11,424 (47.77) | 4,369 (18.27) |
No | 3,912 (2.89) | 886 (22.65) | 522 (58.92) | 470 (53.05) | 168 (18.96) |
χ2 | 50.46* | 2.90 | 9.54* | 0.31 | |
History of myocardial infarction | |||||
Yes | 416 (0.31) | 136 (32.69) | 106 (77.94) | 99 (72.79) | 43 (31.62) |
No | 134,936 (99.69) | 24,665 (18.28) | 13,815 (56.01) | 11,795 (47.82) | 4,494 (18.22) |
χ2 | 57.58* | 21.71* | 33.8* | 16.25* | |
History of stroke | |||||
Yes | 731 (0.54) | 221 (30.23) | 175 (79.19) | 154 (69.68) | 73 (33.03) |
No | 134,621 (99.46) | 24,580 (18.26) | 13,746 (55.92) | 11,740 (47.76) | 4,464 (18.16) |
χ2 | 69.67* | 48.13* | 42.17* | 32.41* | |
History of hypertension | |||||
Yes | 35,991 (26.59) | 11,428 (31.75) | 7,732 (67.66) | 6,725 (58.85) | 2,776 (24.29) |
No | 99,361 (73.41) | 13,373 (13.46) | 6,189 (46.28) | 5,169 (38.65) | 1,761 (13.17) |
χ2 | 5,908.88* | 1,143.74* | 1,006.86* | 511.37* | |
Smoking | |||||
Yes | 34,593 (25.56) | 6,626 (18.04) | 3,590 (54.18) | 3,021 (45.59) | 1,189 (17.94) |
No | 100,759 (74.44) | 18,175 (19.15) | 10,331 (56.84) | 8,873 (48.82) | 3,348 (18.42) |
χ2 | 22.72* | 13.97* | 20.26* | 1.11 | |
Drinking | |||||
Yes | 13,490 (9.97) | 2,666 (19.76) | 1,232 (46.21) | 1,001 (37.55) | 358 (13.43) |
No | 121,862 (90.03) | 22,135 (18.16) | 12,689 (57.33) | 10,893 (49.21) | 4,179 (18.88) |
χ2 | 21.17* | 119.36* | 129.72* | 47.44* | |
Obesity | |||||
Yes | 14,942 (11.04) | 4,063 (27.19) | 2,287 (56.29) | 1,967 (48.41) | 718 (17.67) |
No | 120,410 (88.96) | 20,738 (17.22) | 11,634 (56.10) | 9,927 (47.87) | 3,819 (18.42) |
χ2 | 883.08* | 0.05 | 0.40 | 6.35* | |
Total | 135,352 (100) | 24,801 (18.32) | 13,921 (56.13) | 11,894 (47.96) | 4,537 (18.29) |
P‐values < 0.05.
The data outside the brackets are the number of participants, and inside the brackets are the composition ratios (%).
The data outside the brackets are the number of patients, and inside the brackets are the prevalence rates (%).
The data outside the brackets are the number of those who know they are patients of type 2 diabetes, and inside the brackets are the awareness rates (%).
The data outside the brackets are the number of those who take measures, such as lifestyle intervention or drug therapy among type 2 diabetes patients, and inside the brackets are the treatment rates (%).
The data outside the brackets are the number of those whose fasting plasma glucose were controlled at ≤7.0 mmol/L among type 2 diabetes patients, and inside the brackets are the control rates (%).